Prehosptial low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial

doi:10.1097/TA.0000000000003686

Comment

. 2022 Nov 1;93(5):e175-e176.

doi: 10.1097/TA.0000000000003686. Epub 2022 Jun 14.

Prehosptial low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial

Frank X Guyette, Jason L Sperry

PMID: 35696382
DOI: 10.1097/TA.0000000000003686

Comment

Prehosptial low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial

Frank X Guyette et al. J Trauma Acute Care Surg. 2022.

. 2022 Nov 1;93(5):e175-e176.

doi: 10.1097/TA.0000000000003686. Epub 2022 Jun 14.

Authors

Frank X Guyette, Jason L Sperry

PMID: 35696382
DOI: 10.1097/TA.0000000000003686

No abstract available

PubMed Disclaimer

Comment on

Prehospital low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial.
Guyette FX, Zenati M, Triulzi DJ, Yazer MH, Skroczky H, Early BJ, Adams PW, Brown JB, Alarcon L, Neal MD, Forsythe RM, Zuckerbraun BS, Peitzman AB, Billiar TR, Sperry JL. Guyette FX, et al. J Trauma Acute Care Surg. 2022 May 1;92(5):839-847. doi: 10.1097/TA.0000000000003551. Epub 2022 Jan 25. J Trauma Acute Care Surg. 2022. PMID: 35081595 Free PMC article. Clinical Trial.
Prehospital low titer group O whole blood: Difficult to conclude?
Cazes N, Corcostegui SP, Boutillier du Retail C. Cazes N, et al. J Trauma Acute Care Surg. 2022 Nov 1;93(5):e175. doi: 10.1097/TA.0000000000003637. Epub 2022 Jun 14. J Trauma Acute Care Surg. 2022. PMID: 35696354 No abstract available.

Cited by

Early achievement of hemostasis defined by transfusion velocity: A possible mechanism for whole blood survival benefit.
Chipman AM, Luther JF, Guyette FX, Cotton BA, Cannon JW, Schreiber MA, Moore EE, Namias N, Minei JP, Yazer MH, Vincent L, Cotton AL, Agarwal V, Brown JB, Leeper CM, Neal MD, Forsythe RM, Wisniewski SR, Sperry JL; SWAT Study Group. Chipman AM, et al. J Trauma Acute Care Surg. 2025 Mar 1;98(3):393-401. doi: 10.1097/TA.0000000000004507. Epub 2025 Jan 27. J Trauma Acute Care Surg. 2025. PMID: 39865522 Free PMC article.
Characterization of adverse events in injured patients at risk of hemorrhagic shock: a secondary analysis of three harmonized prehospital randomized clinical trials.
Lorence JM, Donohue JK, Iyanna N, Guyette FX, Gimbel E, Brown JB, Daley BJ, Eastridge BJ, Miller RS, Nirula R, Harbrecht BG, Claridge JA, Phelan HA, Vercruysse G, O'Keeffe T, Joseph B, Neal MD, Sperry JL. Lorence JM, et al. Trauma Surg Acute Care Open. 2024 Jun 25;9(1):e001465. doi: 10.1136/tsaco-2024-001465. eCollection 2024. Trauma Surg Acute Care Open. 2024. PMID: 38933603 Free PMC article.

References

1. Guyette FX, Zenati M, Triulzi DJ, Yazer MH, Skroczky H, Early BJ, et al. Prehospital low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial. J Trauma Acute Care Surg . 2022;92(5):839–847.
1. Guyette FX, Brown JB, Zenati MS, Early-Young BJ, Adams PW, Eastridge BJ, et al.; STAAMP Study Group. Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, randomized clinical trial. JAMA Surg . 2020;156(1):11–20.
1. Li SR, Guyette F, Brown J, Zenati M, Reitz KM, Eastridge B, et al. Early prehospital tranexamic acid following injury is associated with a 30-day survival benefit: a secondary analysis of a randomized clinical trial. Ann Surg . 2021;274(3):419–426.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information

[1] Guyette FX, Zenati M, Triulzi DJ, Yazer MH, Skroczky H, Early BJ, et al. Prehospital low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial. J Trauma Acute Care Surg . 2022;92(5):839–847.

[2] Guyette FX, Zenati M, Triulzi DJ, Yazer MH, Skroczky H, Early BJ, et al. Prehospital low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial. J Trauma Acute Care Surg . 2022;92(5):839–847.

[3] Guyette FX, Brown JB, Zenati MS, Early-Young BJ, Adams PW, Eastridge BJ, et al.; STAAMP Study Group. Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, randomized clinical trial. JAMA Surg . 2020;156(1):11–20.

[4] Guyette FX, Brown JB, Zenati MS, Early-Young BJ, Adams PW, Eastridge BJ, et al.; STAAMP Study Group. Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, randomized clinical trial. JAMA Surg . 2020;156(1):11–20.

[5] Li SR, Guyette F, Brown J, Zenati M, Reitz KM, Eastridge B, et al. Early prehospital tranexamic acid following injury is associated with a 30-day survival benefit: a secondary analysis of a randomized clinical trial. Ann Surg . 2021;274(3):419–426.

[6] Li SR, Guyette F, Brown J, Zenati M, Reitz KM, Eastridge B, et al. Early prehospital tranexamic acid following injury is associated with a 30-day survival benefit: a secondary analysis of a randomized clinical trial. Ann Surg . 2021;274(3):419–426.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Prehosptial low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial

Prehosptial low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial

Authors

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical